11β-Hydroxysteroid dehydrogenase type 1 expression in periprosthetic osteolysis

Orthopedics

Volumn 31, Issue 6, 2008, Pages 1-6

  Tashjian, Robert Z ^a   Lin, Chuzhao ^b   Aswad, Bassam ^b   Terek, Richard M ^b  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b RHODE ISLAND HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE 1; HSD11B1 PROTEIN, HUMAN;

ARTICLE; CELL CULTURE; FIBROBLAST; GENE EXPRESSION; HUMAN; INFECTION; METABOLISM; OSTEOLYSIS;

11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1; CELLS, CULTURED; FIBROBLASTS; GENE EXPRESSION; HUMANS; OSTEOLYSIS; PROSTHESIS-RELATED INFECTIONS;

EID: 64949110880     PISSN: 01477447     EISSN: None     Source Type: Journal    
DOI: 10.3928/01477447-20080601-32     Document Type: Article

References (38)

1. Vermes C, Glant TT, Hallab NJ, Fritz EA, Roebuck KA, Jacobs JJ. The potential role of the osteoblast in the development of periprosthetic osteolysis: review of in vitro osteoblast responses to wear debris, corrosion products, and cytokines and growth factors. J Arthroplasty. 2001; 16(8 suppl 1):95-100. (Pubitemid 33151053)
2. Jacobs JJ, Roebuck KA, Archibeck M, Hallab NJ, Glant TT. Osteolysis: basic science. Clin Orthop Relat Res. 2001; (393):71-77. (Pubitemid 33101699)
3. Shanbhag AS, Jacobs JJ, Black J, Galante JO, Glant TT. Cellular mediators secreted by interfacial membranes obtained at revision total hip arthroplasty. J Arthroplasty. 1995; 10(4):498-506.
4. Goldring SR, Schiller AL, Roelke M, Rourke CM, O'Neil DA, Harris WH. The synovial-like membrane at the bone-cement interface in loose total hip replacements and its proposed role in bone lysis. J Bone Joint Surg Am. 1983; 65(5):575-584. (Pubitemid 13107113)
5. Jiranek WA, Machado M, Jasty M, et al. Production of cytokines around loosened cemented acetabular components: analysis with immunohistochemical techniques and in situ hybridization. J Bone Joint Surg Am. 1993; 75(6):863-879. (Pubitemid 23206699)
6. Glant TT, Jacobs JJ, Molnar G, Shanbhag AS, Valyon M, Galante JO. Bone resorption activity of particulate-stimulated macrophages. J Bone Miner Res. 1993; 8(9):1071-1079. (Pubitemid 23261100)
7. Yao J, Glant TT, Lark MW, et al. The potential role of fibroblasts in periprosthetic osteolysis: fibroblast response to titanium particles. J Bone Miner Res. 1995; 10(9):1417-1427.
8. Shanbhag AS, Jacobs JJ, Black J, Galante JO, Glant TT. Human monocyte response to particulate biomaterials generated in vivo and in vitro. J Orthop Res. 1995; 13(5):792-801.
9. Nakashima Y, Sun DH, Maloney WJ, Goodman SB, Schurman DJ, Smith RL. Induction of matrix metalloproteinase expression in human macrophages by orthopaedic particulate debris in vitro. J Bone Joint Surg Br. 1998; 80(4):694-700. (Pubitemid 28351990)
10. Jilka RL, Hangoc G, Girasole G, et al. Increased osteoclast development after estrogen loss: mediation by interleukin-6. Science. 1992; 257(5066):88-91.
11. Lader CS, Flanagan AM. Prostaglandin E2, interleukin 1-alpha, and tumor necrosis factor-alpha increase human osteoclast formation and bone resorption in vitro. Endocrinology. 1998; 139(7):3157-3164. (Pubitemid 28512345)
12. Kusano K, Miyaura C, Inada M, et al. Regulation of matrix metalloproteinases (MMP-2, -3, -9, and -13) by interleukin-1 and interleukin-6 in mouse calvaria: association of MMP induction with bone resorption. Endocrinology. 1998; 139(3):1338-1345. (Pubitemid 28510155)
13. Vermes C, Chandrasekaran R, Jacobs JJ, Galante JO, Roebuck KA, Glant TT. The effects of particulate wear debris, cytokines, and growth factors on the functions of MG-63 osteoblasts. J Bone Joint Surg Am. 2001; 83(2):201-211. (Pubitemid 32163714)
14. Sakai H, Jingushi S, Shuto T, et al. Fibroblasts from the inner granulation tissue of the pseudocapsule in hips at revision arthroplasty induce osteoclast differentiation, as do stromal cells. Ann Rheum Dis. 2002; 61(2):103-109. (Pubitemid 34098423)
15. Reid IR. Glucocorticoid effects on bone. J Clin Endocrinol Metab. 1998; 83(6):1860-1862. (Pubitemid 28496306)
16. Cooper MS, Hewison M, Stewart PM. Glucocorticoid activity, inactivity and the osteoblast. J Endocrinology. 1999; 163(2):159-164.
17. Cooper MS, Walker EA, Bland R, Fraser WD, Hewison M, Stewart PM. Expression and functional consequences of 11β-hydroxysteroid dehydrogenase activity in human bone. Bone. 2000; 27(3):375-381. (Pubitemid 30658120)
18. Seckl JR, Walker BR. Minireview: 11β-hydroxysteroid dehydrogenase type 1 - a tissue-specific amplifier of glucocorticoid action. Endocrinology. 2001; 142(4):1371-1376. (Pubitemid 32299662)
19. Cooper MS, Bujalska I, Rabbitt E, et al. Modulation of 11β-hydroxysteroid dehydrogenase isozymes by proinflammatory cytokines in osteoblasts: an autocrine switch from glucocorticoid inactivation to activation. J Bone Miner Res. 2001; 16(6):1037-1044. (Pubitemid 32467147)
20. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2-Delta Delta CT method. Methods. 2001; 25(4):402-408. (Pubitemid 34164012)
21. McGough RL, Lin C, Meitner P, Aswad BI, Terek RM. Angiogenic cytokines in cartilage tumors. Clin Orthop. 2002; (397):62-69. (Pubitemid 34442016)
22. Morris DJ, Brem AS, Ge R, Jellinck PH, Sakai RR, Hardy MP. The functional roles of 11β-HSD1: vascular tissue, testis and brain. Mol Cell Endocrinol. 2003; 203(1-2):1-12. (Pubitemid 36627583)
23. Ricketts ML, Verhaeg JM, Bujalska I, Howie AJ, Rainey WE, Stewart PM. Immunohistochemical localization of type 1 11β-hydroxysteroid dehydrogenase in human tissues. J Clin Endocrinol Metab. 1998; 83(4):1325-1335. (Pubitemid 28496416)
24. Cushing H. The basophil adenomas of the pituitary body and their clinical manifestations (pituitary basophilism). Bull Johns Hopkins Hosp. 1932; 1:137-192.
25. Delany AM, Gabbitas BY, Canalis E. Cortisol downregulates osteoblast alpha1 (1) procollagen mRNA by transcriptional and posttranscriptional mechanisms. J Cell Biochem. 1995; 57(3):488-494.
26. Pereira RM, Delany AM, Canalis E. Cortisol inhibits the differentiation and apoptosis of osteoblasts in culture. Bone. 2001; 28(5):484-490. (Pubitemid 32409999)
27. Weinstein RS, Jilka RL, Parfitt AM, Manolagas SC. Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids: potential mechanisms of their deleterious effects on bone. J Clin Invest. 1998; 102(2):274-282. (Pubitemid 28335186)
28. Hofbauer LC, Gori F, Riggs BL, et al. Stimulation of osteoprotegerin ligand and inhibition of osteoprotegerin production by glucocorticoids in human osteoblastic lineage cells: potential paracrine mechanisms of glucocorticoid-induced osteoporosis. Endocrinology. 1999; 140(10):4382-4389. (Pubitemid 30666099)
29. Chiodini I, Carnevale V, Torlontano M, et al. Alterations of bone turnover and bone mass at different skeletal sites due to pure glucocorticoid excess: study in eumenorrheic patients with Cushing's syndrome. J Clin Endocrinol Metab. 1998; 83(6):1863-1867. (Pubitemid 28496307)
30. Dennison E, Hindmarsh P, Fall C, et al. Profiles of endogenous circulating cortisol and bone mineral density in healthy elderly men. J Clin Endocrinol Metab. 1999; 84(9):3058-3063. (Pubitemid 30646923)
31. Huizenga NATM, Koper JW, De Lange P, et al. A polymorphism in the glucocorticoid receptor gene may be associated with an increased sensitivity to glucocorticoids in vivo. J Clin Endocrinol Metab. 1998; 83(1):144-151.
32. Canalis E, Delany AM. 11beta-hydroxysteroid dehydrogenase, an amplifier of glucocorticoid action in osteoblasts. J Bone Miner Res. 2002; 17(6):987-990. (Pubitemid 34535136)
33. Bukata SV, Gelinas J, Wei X, et al. PGE2 and IL-6 production by fibroblasts in response to titanium wear debris particles is mediated through a Cox-2 dependent pathway. J Orthop Res. 2004; 22(1):6-12. (Pubitemid 38035439)
34. Konttinen YT, Kurvinen H, Takagi M, et al. Interleukin-1 and collagenases around loosening total hip prostheses. Clin Exp Rheumatol. 1996; 14(3):255-262. (Pubitemid 26290865)
35. Jones LC, Frondoza C, Hungerford DS. Immunohistochemical evaluation of interface membranes from failed cemented and uncemented acetabular components. J Biomed Mater Res. 1999; 48(6):889-898.
36. Thieringer R, Le Grand CB, Carbin L, et al. 11β-hydroxysteroid dehydrogenase type 1 is induced in human monocytes upon differentiation to macrophages. J Immunol. 2001; 167(1):30-35. (Pubitemid 32567757)
37. Alberts P, Engblom L, Edling N, et al. Selective inhibition of 11β-hydroxysteroid dehydrogenase type 1 decreases blood glucose concentrations in hyperglycaemic mice. Diabetologia. 2002; 45(11):1528-1532. (Pubitemid 35352046)
38. Schweizer RAS, Atanasov AG, Frey BM, Odermatt A. A rapid screening assay for inhibitors of 11β-hydroxysteroid dehydrogenases (11β-HSD): flavanone selectively inhibits 11β-HSD1 reductase activity. Mol Cell Endocrinol. 2003; 212(1-2):41-49. (Pubitemid 37488027)